Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone.

× No keyword cloud information.

35 in total

1. THE ACTION OF INSULIN IN MAN IN THE POSTABSORPTIVE AND POSTPRANDIAL STATES WITH A NOTE ON SOME APPLICATIONS OF ITS ACTION IN DETERMINING MUSCLE FUEL IN MAN.

Authors: D RABINOWITZ; K L ZIERLER
Journal: Postgrad Med J Date: 1965-02 Impact factor: 2.401

2. Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration.

Authors: E F PFEIFFER; M PFEIFFER; H DITSCHUNEIT; C S AHN
Journal: Ann N Y Acad Sci Date: 1959-09-25 Impact factor: 5.691

3. The inhibition of insulinase by hypoglycemic sulfonamides.

Authors: I A MIRSKY; G PERISUTTI; D DIENGOTT
Journal: Metabolism Date: 1956-03 Impact factor: 8.694

4. Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics.

Authors: B F Clarke; I W Campbell
Journal: Lancet Date: 1975-02-01 Impact factor: 79.321

Review 5. Appraisal of the extrapancreatic actions of sulfonylureas.

Authors: J M Feldman; H E Lebovitz
Journal: Arch Intern Med Date: 1969-03

6. Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.

Authors: G M Shenfield; A Logan; D Shirling; J Baird
Journal: Diabetologia Date: 1977-08 Impact factor: 10.122

7. The effects of energy and carbohydrate restriction in patients with chronic diabetes mellitus.

Authors: J R Perkins; T E West; P H Sönksen; C Lowy; C Iles
Journal: Diabetologia Date: 1977-12 Impact factor: 10.122

8. Clinical and metabolic study in diabetic patients treated with glibenclamide.

Authors: J Anderson; R Coulson; B D Grassick; B A Morris; W D Thomas; R W Tomlihson; F Woodroffe
Journal: Br Med J Date: 1970-06-06

9. Assessment of the need for continued oral therapy in diabetics.

Authors: A M Tomkins; A Bloom
Journal: Br Med J Date: 1972-03-11

10. The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.

Authors: E Tsalikian; T W Dunphy; N V Bohannon; M Lorenzi; J E Gerich; P H Forsham; J P Kane; J H Karam
Journal: Diabetes Date: 1977-04 Impact factor: 9.461

6 in total

1. Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.

Authors: E Bonora; P Moghetti; M Querena; M Zenere; V Cacciatori; F Tosi; D Travia; G Zoppini; M Muggeo
Journal: J Endocrinol Invest Date: 1992-01 Impact factor: 4.256

Review 2. The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors: R E Ferner; S Chaplin
Journal: Clin Pharmacokinet Date: 1987-06 Impact factor: 6.447

Review 3. Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.

Authors: R Huupponen
Journal: Med Toxicol Date: 1987 May-Jun

4. The effect of acebutolol and propranolol on the hypoglycaemic action of glibenclamide.

Authors: R Zaman; M J Kendall; P I Biggs
Journal: Br J Clin Pharmacol Date: 1982-04 Impact factor: 4.335

5. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.

Authors: P Serradas; D Bailbé; B Portha
Journal: Diabetologia Date: 1989-08 Impact factor: 10.122

6. Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

Authors: J P Hosker; M A Burnett; E G Davies; E A Harris; R C Turner
Journal: Diabetologia Date: 1985-11 Impact factor: 10.122

6 in total